论文部分内容阅读
目的观察卡培他滨对胃癌患者的疗效。方法回顾性分析本院2012年3月～2013年1月收治的20例胃癌患者的临床资料,采用卡培他滨治疗,观察治疗后的效果。结果治疗后,完全缓解3例,部分缓解6例,稳定5例,进展6例,治疗总有效率达45%。患者不良反应多为1度毒性反应,对患者身体影响不明显。患者不良症状得以改善,满意度提高,治疗前后差异有统计学意义(P<0.05)。结论卡培他滨在胃癌的治疗中有较好的效果,虽有副作用,但不影响治疗效果,对于老年患者特别适宜。
Objective To observe the effect of capecitabine on gastric cancer patients. Methods The clinical data of 20 patients with gastric cancer who were treated in our hospital from March 2012 to January 2013 were retrospectively analyzed. The effect of treatment with capecitabine was observed. Results After treatment, complete remission in 3 cases, partial remission in 6 cases, stable in 5 cases, progress in 6 cases, the total effective rate of 45%. Adverse reactions in patients with mostly 1 degree toxicity, the impact on the patient’s body is not obvious. Patients with adverse symptoms can be improved, satisfaction increased, before and after treatment, the difference was statistically significant (P <0.05). Conclusion Capecitabine has a good effect in the treatment of gastric cancer, although side effects, but does not affect the treatment effect, especially suitable for elderly patients.